2 alpha, 3 alpha-epithio-5 alpha-androstan-17 beta-OL in the treatment of chronic mastopathy.
D000152:Acne Vulgaris / Q000139:chemically induced; D000328:Adult; D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001835:Body Weight; D001941:Breast Diseases / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004487:Edema / Q000139:chemically induced; D005260:Female; D006628:Hirsutism / Q000139:chemically induced; D006685:Hoarseness / Q000139:chemically induced; D006801:Humans; D008599:Menstruation Disturbances / Q000139:chemically induced; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced
D045930:Anabolic Agents